Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer-Reference-Cited by-同舟云学术

Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer

Published:2023 Issue:5 Volume:34 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Kotaka Saki¹²^ORCID,Kondo Eiji²^ORCID,Kawai Yosuke³^ORCID,Okamoto Kota²^ORCID,Kishigami Yasuyuki⁴^ORCID,Yamawaki Takaharu⁵^ORCID,Nagao Kenji⁶^ORCID,Hirata Toru⁷^ORCID,Suzuki Shiro¹^ORCID

Affiliation:

1. Department of Gynecologic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.

2. Department of Obstetrics and Gynecology, Mie University School of Medicine, Tsu, Japan.

3. Department of Obstetrics and Gynecology, Toyohashi Municipal Hospital, Toyohashi, Japan.

4. Department of Obstetrics and Gynecology, Toyota Memorial Hospital, Toyota, Japan.

5. Department of Obstetrics and Gynecology, Ise Red Cross Hospital, Ise, Japan.

6. Department of Obstetrics and Gynecology, Yokkaichi Municipal Hospital, Yokkaichi, Japan.

7. Department of Obstetrics and Gynecology, Kuwana City Medical Center, Kuwana, Japan.

Publisher

XMLink

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2023.34.e60

Reference20 articles.

1. World Health Organization International Agency for Research on Cancer. Cancer today [Internet]. Lyon. World Health Organization International Agency for Research on Cancer. 2023. cited 2023 Feb 26. Available from: https://gco.iarc.fr/today/home

2. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

3. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

4. Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079)

5. A Single Arm Prospective Pilot Study Examining the Efficacy and Safety of Bevacizumab Single Maintenance Therapy Following Platinum-Based Chemotherapy in Patients with Advanced or Recurrent Cervical Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paclitaxel‐carboplatin plus bevacizumab therapy for advanced neuroendocrine carcinoma of the uterine cervix: A retrospective case series;Journal of Obstetrics and Gynaecology Research;2023-09-02